Febbo Phillip G. 4
4 · VERACYTE, INC. · Filed Oct 7, 2025
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Sale
Common Stock
2025-10-06$36.02/sh−8,349$300,709→ 92,441 total
Footnotes (2)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $35.82 to $36.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.